Rajesh Jain, joint managing director, Panacea Biotec expects the USFDA approval for the collaborated drug by next year to early-2016.
first published: Dec 19, 2014 03:00 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

